Both monosomies and trisomies decrease cellular fitness. by Dorine C. Hintzen (12988183)

TREM1 inhibition decreases HIV mediated inflammatory cytokine production. by Jinhee Hyun (6900683)

A genetic variant in human FIRE is associated with a decreased interferon response in myeloid cells. by Anaïs Assouvie (9600529)

Marker genes for the myeloid clusters. by Emilie Pollenus (10147748)

Effect of the natural sequencing read placement uncertainty on euploid sample group number of false-positive trisomy 21 cases. by Priit Paluoja (6927959)

Proinflammatory signaling pathways were decreased in Ad26.COV2.S vaccinated compared to sham unvaccinated hamsters. by Malika Aid (7303874)

Identification of TCN as a novel myeloid differentiation inducer. by Souma Suzuki (18554923)

The values approximated and calculated for and for the WT and each mutant Abl1 enzyme. by J. Roadnight Sheehan (20141887)

Subjects:

A visual comparison of the associated resistance data from Table 1 with the values of <i>k</i>_cat, <i>K</i>_M, catalytic efficiency (<i>k</i>_cat/<i>... by J. Roadnight Sheehan (20141887)

Subjects:

The values for <i>k</i>_cat and <i>K</i>_M are sourced from [19]. by J. Roadnight Sheehan (20141887)

Subjects:

The values for and with the resultant ΔΔ<i>G</i>_Mut, found through FEP simulations. ΔΔ<i>G</i>_Mut for the wild-type is 0 kcal/mol. by J. Roadnight Sheehan (20141887)

Subjects:

The table (refined data from [14]) shows the mutants associated with resistance for imatinib, ponatinib, and dasatinib. by J. Roadnight Sheehan (20141887)

Subjects:

The enzyme states and their relative weights within the system in quasi-equilibrium. by J. Roadnight Sheehan (20141887)

Subjects:

A heat map to compare the associated resistances outlined in Table 1 and [14] with the IRP values. by J. Roadnight Sheehan (20141887)

Subjects:

How the variation in inhibitor concentration throughout one day affects the value of IC₅₀/(IC₅₀ + [R]) for different Abl1 inhibitors. by J. Roadnight Sheehan (20141887)

Subjects:

We define the term “inhibitory reduction prowess” (IRP) as the percentage by which the product formation rate is reduced by from the initial point before inhibitor is introduced to... by J. Roadnight Sheehan (20141887)

Subjects:

The values calculated for the inhibitor dissociation constant, as detailed in Eqs 10 and 11 and approximated values for the binding rate constants of the inhibitors. by J. Roadnight Sheehan (20141887)

Subjects:

Values for the calculation of the time-dependent drug concentrations in the system based on observed data found and derived from a variety of sources. by J. Roadnight Sheehan (20141887)

Subjects:

To bridge two naming conventions (one more suitable to mathematical notation and one more conventional in enzymology), the table matches the rate constants as described in Eq 2 to... by J. Roadnight Sheehan (20141887)

Subjects:

A cartoon of the simplified model of the Abl1 enzyme system. by J. Roadnight Sheehan (20141887)

Subjects: